Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Berger

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 20, 1982
Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotypeG M Berger, J H Van der Westhuyzen, J Huskisson, et al.
Arteriosclerosis (Dallas, Tex.)|July 1, 1982
Low density lipoprotein metabolism in cultured fibroblasts from a new group of patients presenting clinically with homozygous familial hypercholesterolemiaG A Coetzee, D R van der Westhuyzen, G M Berger, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 21, 1976
Portacaval shunt in two patients with homozygous type II hyperlipoproteinaemiaS Cywes, M R Davies, J H Louw, et al.
Pediatric Research|October 1, 1983
Absence of serum-stimulated lipase activity and altered lipid content in milk from a patient with type I hyperlipoproteinaemiaG M Berger, A Spark, P M Baillie, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 16, 1998
Molecular diagnosis of multiple endocrine neoplasia type 2AR J Pegoraro, D J Hacking, R H Buck, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 18, 1988
Action limits for serum total cholesterol. A statement for the medical profession by an ad hoc committee of the Heart Foundation of Southern AfricaJ E Rossouw, K Steyn, G M Berger, et al.
The Journal of Clinical Investigation|October 1, 1990
Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defectsD C Rubinsztein, J C Cohen, G M Berger, et al.
Cardiovascular Drugs and Therapy|April 1, 1989
Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatinG M Berger, A D Marais, H C Seftel, et al.
Nanotechnology|October 16, 2012
A novel methane sensor based on porous SnO2 nanorods: room temperature to high temperature detectionA Biaggi-Labiosa, F Solá, M Lebrón-Colón, et al.
Journal of Lipid Research|June 4, 1998
HMG-CoA reductase is not the site of the primary defect in phytosterolemiaG M Berger, R J Pegoraro, S B Patel, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 20, 1982
Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotypeG M Berger, J H Van der Westhuyzen, J Huskisson, et al.
Arteriosclerosis (Dallas, Tex.)|July 1, 1982
Low density lipoprotein metabolism in cultured fibroblasts from a new group of patients presenting clinically with homozygous familial hypercholesterolemiaG A Coetzee, D R van der Westhuyzen, G M Berger, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 21, 1976
Portacaval shunt in two patients with homozygous type II hyperlipoproteinaemiaS Cywes, M R Davies, J H Louw, et al.
Pediatric Research|October 1, 1983
Absence of serum-stimulated lipase activity and altered lipid content in milk from a patient with type I hyperlipoproteinaemiaG M Berger, A Spark, P M Baillie, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 16, 1998
Molecular diagnosis of multiple endocrine neoplasia type 2AR J Pegoraro, D J Hacking, R H Buck, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 18, 1988
Action limits for serum total cholesterol. A statement for the medical profession by an ad hoc committee of the Heart Foundation of Southern AfricaJ E Rossouw, K Steyn, G M Berger, et al.
The Journal of Clinical Investigation|October 1, 1990
Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defectsD C Rubinsztein, J C Cohen, G M Berger, et al.
Cardiovascular Drugs and Therapy|April 1, 1989
Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatinG M Berger, A D Marais, H C Seftel, et al.
Nanotechnology|October 16, 2012
A novel methane sensor based on porous SnO2 nanorods: room temperature to high temperature detectionA Biaggi-Labiosa, F Solá, M Lebrón-Colón, et al.
Journal of Lipid Research|June 4, 1998
HMG-CoA reductase is not the site of the primary defect in phytosterolemiaG M Berger, R J Pegoraro, S B Patel, et al.
Pageof 6